PFIZER INC Additional Collateral, Aggregate Fair Value
PFIZER INC (PFE) had Additional Collateral, Aggregate Fair Value of $4.00 million as of 2016-07-03, per its 10-Q filed 2016-08-11.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments
us-gaap:AdditionalCollateralAggregateFairValue · last filed 2016-08-11
- 2016-07-03: Additional Collateral, Aggregate Fair Value $4.00M.
- 2016-04-03: Additional Collateral, Aggregate Fair Value $13.00M.
- 2015-12-31: Additional Collateral, Aggregate Fair Value $20.00M.
- 2015-09-27: Additional Collateral, Aggregate Fair Value $35.00M.
| Period end | Additional Collateral, Aggregate Fair Value |
|---|---|
| 2016-07-03 | $4.00M 10-Q · filed 2016-08-11 |
| 2016-04-03 | $13.00M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $20.00M 10-K · filed 2016-02-29 |
| 2015-09-27 | $35.00M 10-Q · filed 2015-11-05 |
| 2015-06-28 | $14.00M 10-Q · filed 2015-08-06 |
| 2015-03-29 | $21.00M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $5.00M 10-K · filed 2015-02-27 |
| 2014-09-28 | $27.00M 10-Q · filed 2014-11-06 |
| 2014-06-29 | $3.00M 10-Q · filed 2014-08-07 |
| 2013-12-31 | $32.00M 10-K · filed 2014-02-28 |
| 2011-04-03 | $93.90M 10-Q · filed 2011-05-12 |
| 2010-12-31 | $194.00M 10-K · filed 2011-02-28 |
| 2010-10-03 | $29.00M 10-Q · filed 2010-11-12 |
| 2010-07-04 | $54.00M 10-Q · filed 2010-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |